Description

5,6,7,9-Tetrahydro-8H-Pyrido[2,3-B]Azepin-8-One is a heterocyclic organic compound featuring a fused pyridoazepinone structure, serving as a critical advanced intermediate in modern synthetic chemistry. Its unique molecular scaffold makes it a valuable building block for the development of novel pharmacologically active compounds, particularly in central nervous system (CNS) and oncology research. This high-purity intermediate is essential for pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of complex active pharmaceutical ingredients (APIs) and other specialty chemicals.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the multi-step synthesis of complex drug candidates and active pharmaceutical ingredients (APIs).
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and the discovery of new therapeutic agents.
• Organic Synthesis Building Block: Used in the construction of complex nitrogen-containing heterocycles for various fine chemical applications.
• CNS Drug Development: Particularly relevant in the research and synthesis of compounds targeting neurological and psychiatric disorders.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional laboratories for methodological studies in heterocyclic and synthetic organic chemistry.

Basic Information

Product Name	5,6,7,9-Tetrahydro-8H-Pyrido[2,3-B]Azepin-8-One
CAS No.	67046-22-4
Molecular Formula	C10H12N2O
Molecular Weight	176.22 g/mol
Synonyms	8H-Pyrido[2,3-b]azepin-8-one, 5,6,7,9-tetrahydro-; 5,6,7,9-Tetrahydro-8H-pyrido[2,3-b]azepin-8-one; Pyrido[2,3-b]azepin-8(9H)-one, 5,6,7,9-tetrahydro-; Tetrahydro-8H-pyrido[2,3-b]azepin-8-one; 67046-22-4; 8H-Pyrido[2,3-b]azepin-8-one, tetrahydro-; 5,6,7,9-Tetrahydro-8H-pyrido[2,3-b]azepin-8-one (ACI)
EINECS	Contact for details

Quality Control

Our 5,6,7,9-Tetrahydro-8H-Pyrido[2,3-B]Azepin-8-One is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for research and development applications. Each lot undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting all critical quality attributes. We adhere to cGMP principles where applicable to support our clients' regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed after each use to prevent moisture absorption, which may affect stability and handling properties. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.